Table 3.
Univariate analysis for PFS in patients with uterine carcinosarcoma (n=199)
| Number of patients | Number of events | Three-year PFS (±SE) rate | P-value | |
|---|---|---|---|---|
| All | 199 | 90 | — | 0.13 |
| SLN | 99 | 37 | 62.9 (±5.2) | |
| LND | 100 | 51 | 52.3 (±5.3) | |
| Procedure | 0.39 | |||
| Laparotomy | 99 | 50 | 57.0 (±5.3) | |
| MIS | 100 | 40 | 57.8 (±5.4) | |
| Stage | <0.001 | |||
| I | 116 | 40 | 66.7 (±4.7) | |
| II | 17 | 6 | 79.6 (±10.6) | |
| III | 57 | 36 | 38.5 (±7.1) | |
| IV | 9 | 8 | 16.7 (±14.2) | |
| Myometrial invasion | 0.001 | |||
| <50% | 129 | 48 | 65.9 (±4.5) | |
| ≥50% | 69 | 42 | 41.7 (±6.4) | |
| LVSI | 0.66 | |||
| Present | 91 | 41 | 53.9 (±5.7) | |
| Absent | 104 | 48 | 60.0 (±5.1) | |
| Suspicious | 1 | 0 | — | |
| Peritoneal washings | 0.01 | |||
| Positive | 43 | 28 | 64.1 (±4.4) | |
| Negative | 139 | 54 | 36.3 (±7.8) | |
| Suspicious | 3 | 1 | — |
Data are expressed as n (%) unless otherwise specified.
LVSI, lymphovascular space invasion; MIS, minimally invasive surgery; SE, standard error.